Circulating Tumor Cell Market is Expected to Reach $5.9 Billion Globally by 2031 at a CAGR of 18.0%: Allied Market Research
RRising number of cancer cases, increased awareness of CTCs and their detection in cancer diagnosis, increase in research and development activities and increase in clinical trials are driving the growth of the global circulating tumor cell market . PORTLAND, Oregon., December 9, 2022 /PRNewswire/ — Allied Market Research has released a report titled, “Circulating Tumor …
